Lifecore Biomedical Inc (NAS:LFCR)
$ 7.41 -0.085 (-1.13%) Market Cap: 272.89 Mil Enterprise Value: 404.23 Mil PE Ratio: 148.20 PB Ratio: 0 GF Score: 65/100

Q1 2020 Landec Corp Earnings Call Transcript

Oct 02, 2019 / 03:00PM GMT
Release Date Price: $10.48 (-2.60%)
Operator

Good morning, and thank you for joining Landec's First Quarter of Fiscal Year 2020 Earnings Call. With me on the call is Dr. Albert Bolles, Landec's Chief Executive Officer; and Greg Skinner, Landec's Chief Financial Officer.

During today's call, we may make forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially. These risks are outlined in our filings with the Securities and Exchange Commission, including the company's Form 10-K for fiscal year 2019.

Let me turn the call over to Al Bolles.

Albert D. Bolles
Landec Corporation - CEO, President & Director

Thank you, and good morning, everyone. As a leading innovator in diversified health and wellness solutions, Landec is comprised of 2 operating businesses, Lifecore Biomedical and Curation Foods.

Lifecore Biomedical is a fully integrated contract development and manufacturing organization or CDMO that offers highly differentiated capabilities for development, fill and finish of difficult-to-manufacture

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot